What is the recommended treatment for an adult diagnosed with pertussis (whooping cough)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 29, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Pertussis in Adults

First-Line Antibiotic Treatment

Adults with confirmed or suspected pertussis should receive azithromycin 500 mg on day 1, followed by 250 mg daily on days 2-5, as this is the preferred macrolide antibiotic due to superior tolerability, better compliance, and equal efficacy compared to erythromycin. 1, 2, 3

Why Azithromycin is Preferred

  • Azithromycin has significantly higher completion rates (93%) compared to erythromycin (57%), primarily due to fewer gastrointestinal side effects 4
  • The shorter 5-day course improves adherence compared to the 14-day erythromycin regimen 1, 3
  • Azithromycin does not inhibit cytochrome P450 enzymes, avoiding drug interactions that occur with erythromycin and clarithromycin 3
  • Clinical trials demonstrate equal microbiologic eradication rates between azithromycin and erythromycin (100% vs 96%) 5, 6

Alternative Macrolide Options

  • Clarithromycin can be used as an alternative: 500 mg twice daily for 7 days 1, 3
  • Erythromycin should only be used when azithromycin is unavailable: 500 mg four times daily for 14 days 1, 7
  • Erythromycin causes uncomfortable gastrointestinal side effects in 76% of patients, with 91% reporting gastrointestinal upset 4

For Macrolide-Intolerant Patients

  • Trimethoprim-sulfamethoxazole (TMP-SMZ) is the alternative for patients with macrolide contraindications or hypersensitivity 1, 3

Critical Timing Considerations

Start antibiotics immediately upon clinical suspicion without waiting for diagnostic confirmation, as early treatment during the catarrhal phase (first 2 weeks) rapidly clears B. pertussis from the nasopharynx, decreases coughing paroxysms, and reduces complications. 1, 2, 3

Treatment Effectiveness by Disease Stage

  • Early treatment (catarrhal phase, first 2 weeks): Maximum clinical benefit—reduces duration and severity of symptoms by approximately 50% 1, 2, 3
  • Late treatment (paroxysmal phase, >3 weeks): Limited clinical benefit for symptom reduction, but still indicated to prevent transmission to others 1, 2, 3
  • Antibiotic treatment generally does not modify the course of illness after cough onset, but is essential for infection control 1
  • Approximately 80-90% of untreated patients spontaneously clear B. pertussis within 3-4 weeks from cough onset 1, 3

Isolation and Infection Control

Isolate patients at home and away from work/school for 5 days after starting antibiotics to prevent transmission, as pertussis is highly contagious with secondary attack rates exceeding 80% among susceptible contacts. 1, 2, 3

  • Without antibiotics, patients must remain isolated for 21 days after cough onset 2, 3
  • Patients can return to work/school after completing 5 days of antibiotic treatment 2, 3

Postexposure Prophylaxis for Contacts

Use the same antibiotic regimens and dosing as for treatment (azithromycin 500 mg day 1, then 250 mg days 2-5) for all close contacts within 21 days of exposure. 1, 2, 3

High-Priority Groups Requiring Prophylaxis

  • All household contacts regardless of vaccination status 2, 3
  • Infants <12 months (highest risk for severe complications and death) 1
  • Pregnant women in third trimester 2, 3, 8
  • Healthcare workers with known exposure 2

Diagnostic Confirmation

Obtain nasopharyngeal aspirate or Dacron swab for culture to confirm diagnosis, though treatment should not be delayed while awaiting results. 1, 2, 3

  • Culture is the only certain way to make the diagnosis 1, 3
  • PCR testing has replaced culture as the preferred confirmatory test in clinical practice 8
  • Suspect pertussis when cough lasts ≥2 weeks with paroxysms, post-tussive vomiting, and/or inspiratory whooping 1, 2

Therapies to Avoid

Do not use β-agonists, antihistamines, corticosteroids, or pertussis immunoglobulin, as these have no proven benefit in controlling coughing paroxysms or improving outcomes. 1, 2, 3

  • These adjunctive therapies are ineffective for symptom control despite theoretical rationale 1, 3

Important Drug Interactions and Precautions

  • Azithromycin should not be taken with aluminum- or magnesium-containing antacids as they reduce absorption 2, 3
  • Erythromycin and clarithromycin (but NOT azithromycin) inhibit cytochrome P450 enzymes and can interact with digoxin, triazolam, and ergot alkaloids 1, 3
  • Obtain baseline ECG before initiating azithromycin in patients taking medications that prolong QTc interval (e.g., citalopram) 3

Vaccination Considerations

  • Vaccine immunity wanes after 5-10 years, making previously vaccinated adults susceptible to infection 1
  • Neither vaccination nor natural disease confers lifelong protective immunity 1
  • Adults up to age 65 should receive a single dose of Tdap vaccine according to CDC guidelines 1
  • Pregnant women should receive Tdap between 27-36 weeks' gestation with each pregnancy to convey immunity to the newborn 2, 8

Common Pitfalls to Avoid

  • Do not delay treatment waiting for culture confirmation—start antibiotics immediately upon clinical suspicion 1, 2, 3
  • Do not assume vaccination provides complete protection—breakthrough infections occur due to waning immunity 1
  • Do not discontinue antibiotics early even if symptoms persist—the primary goal is eradication of bacteria and prevention of transmission, not symptom relief 1, 2, 3
  • Do not forget to treat all household contacts—prophylaxis is essential regardless of vaccination status 2, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment Algorithm for Whooping Cough (Pertussis)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Pertussis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Pertussis: Common Questions and Answers.

American family physician, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.